- Home
- MLYS vs CRSR Comparison
MLYS vs CRSR Comparison
Compare MLYS & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- CRSR
- Stock Information
- Founded
- MLYS 2019
- CRSR 1994
- Country
- MLYS United States
- CRSR United States
- Employees
- MLYS N/A
- CRSR N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- MLYS Health Care
- CRSR Technology
- Exchange
- MLYS Nasdaq
- CRSR Nasdaq
- Market Cap
- MLYS 893.0M
- CRSR 1.1B
- IPO Year
- MLYS 2023
- CRSR 2020
- Fundamental
- Price
- MLYS $14.66
- CRSR $9.11
- Analyst Decision
- MLYS Strong Buy
- CRSR Buy
- Analyst Count
- MLYS 3
- CRSR 6
- Target Price
- MLYS $27.00
- CRSR $10.17
- AVG Volume (30 Days)
- MLYS 2.0M
- CRSR 873.0K
- Earning Date
- MLYS 05-08-2025
- CRSR 05-06-2025
- Dividend Yield
- MLYS N/A
- CRSR N/A
- EPS Growth
- MLYS N/A
- CRSR N/A
- EPS
- MLYS N/A
- CRSR N/A
- Revenue
- MLYS N/A
- CRSR $1,316,379,000.00
- Revenue This Year
- MLYS N/A
- CRSR $16.15
- Revenue Next Year
- MLYS N/A
- CRSR $10.40
- P/E Ratio
- MLYS N/A
- CRSR N/A
- Revenue Growth
- MLYS N/A
- CRSR N/A
- 52 Week Low
- MLYS $8.24
- CRSR $5.60
- 52 Week High
- MLYS $18.38
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- MLYS 56.01
- CRSR 34.97
- Support Level
- MLYS $16.15
- CRSR $9.57
- Resistance Level
- MLYS $17.21
- CRSR $10.41
- Average True Range (ATR)
- MLYS 1.30
- CRSR 0.50
- MACD
- MLYS -0.03
- CRSR -0.17
- Stochastic Oscillator
- MLYS 36.19
- CRSR 0.43
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.